Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vericel Corporation
(NQ:
VCEL
)
51.94
-0.39 (-0.75%)
Streaming Delayed Price
Updated: 2:48 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
202,872
Open
52.44
Bid (Size)
51.90 (4)
Ask (Size)
51.97 (1)
Prev. Close
52.33
Today's Range
51.50 - 52.50
52wk Range
28.02 - 52.43
Shares Outstanding
46,631,158
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Scoreboard: 5 Ratings For Vericel
March 26, 2024
Via
Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
Performance
YTD
+48.91%
+48.91%
1 Month
+8.03%
+8.03%
3 Month
+46.81%
+46.81%
6 Month
+46.23%
+46.23%
1 Year
+84.45%
+84.45%
More News
Read More
A Closer Look at 4 Analyst Recommendations For Vericel
March 01, 2024
Via
Benzinga
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
February 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
February 27, 2024
From
Vericel Corporation
Via
GlobeNewswire
HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know
January 16, 2024
Via
Benzinga
Analyst Ratings for Vericel
October 16, 2023
Via
Benzinga
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
February 26, 2024
Via
InvestorPlace
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
February 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
5 medical stocks growing earnings by triple digits
February 06, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 05, 2024
From
Vericel Corporation
Via
GlobeNewswire
Analyst Ratings for Vericel
September 21, 2023
Via
Benzinga
Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session
January 23, 2024
Via
Investor Brand Network
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
January 09, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
January 03, 2024
From
Vericel Corporation
Via
GlobeNewswire
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
December 28, 2023
Via
Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
Via
InvestorPlace
3 Strong Buy Stocks Set to Take Off in the Coming Months
November 10, 2023
Via
InvestorPlace
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
November 08, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Stephens Annual Investment Conference
November 07, 2023
From
Vericel Corporation
Via
GlobeNewswire
Earnings Scheduled For November 8, 2023
November 08, 2023
Via
Benzinga
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
October 25, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
September 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
September 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.